July 30, 2008Open Access

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

Key Points

Key points are not available for this paper at this time.

Abstract

As compared with D2 lymphadenectomy alone, treatment with D2 lymphadenectomy plus PAND does not improve the survival rate in curable gastric cancer. (ClinicalTrials.gov number, NCT00149279.)

D2 Lymphadenectomy Alone or with Para-aortic Nodal Dissection for Gastric Cancer

Key Points

Abstract

Cite This Study